Restoring Insulin Secretion Pediatric Medication Study
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 05 Oct 2017
At a glance
- Drugs Insulin glargine (Primary) ; Metformin (Primary)
- Indications Prediabetic-state; Type 2 diabetes mellitus
- Focus Biomarker; Therapeutic Use
- Acronyms RISE Peds
- 05 Apr 2016 Planned End Date changed from 1 Aug 2017 to 1 Jan 2018 as reported by ClinicalTrials.gov.
- 05 Apr 2016 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 01 Apr 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.